Conversion of s-lignin compounds to useful intermediates
AssigneeAlliance for Sustainable Energy, LLC
InventorsGregg Tyler BECKHAM, Christopher W. JOHNSON, Sandra Fabienne NOTONIER
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a genetically modified microbial cell that includes a genetic modification resulting in the expression of a vanillate demethylase, where the microbial cell is capable of metabolizing at least one S-lignin decomposition molecule including at least one of syringate and/or 3-O-methyl gallate, and the genetically modified microbial cell is capable of producing gallate. In some embodiments of the present disclosure, the vanillate demethylase may include VanAB.
Claims20
A genetically modified microbial cell comprising:
- a genetic modification resulting in the expression of a vanillate demethylase, wherein:
- the microbial cell is capable of metabolizing at least one S-lignin decomposition molecule comprising at least one of syringate or 3-O-methyl gallate, and
- the genetically modified microbial cell is capable of producing gallate.
A method for making at least one of 2-hydroxy-2H-pyran-4,6-dicarboxylic acid (PDC), (1E,3E)-4-hydroxybuta-1,3-diene-1,2,4-tricarboxylic acid, (1E)-4-oxobut-1-ene-1,2,4-tricarboxylic acid, 2-hydroxy-4-oxobutane-1,2,4-tricarboxylic acid, oxaloacetate, or pyruvate comprising exposing a genetically modified microbial cell to a solution containing at least one of S-lignin decomposition molecules, syringate or 3-O-methyl gallate wherein the genetically modified microbial cell comprises a genetic modification that results in the expression of vanillate demethylase.
Dependencies are inferred from the claim text.